The structure and function of eukaryotic protein glycosylation enzymes
真核蛋白质糖基化酶的结构和功能
基本信息
- 批准号:10412104
- 负责人:
- 金额:$ 42.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-06-18 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAntigensArchitectureAsparagineBindingBinding ProteinsBiological AssayCA-125 AntigenCA-19-9 AntigenCarbohydratesCatalytic DomainCellular biologyClassificationCo-Translational Protein ProcessingComplexCryoelectron MicroscopyCrystallizationDevelopmentDiagnosisEnzymesFoundationsGlycoproteinsGlycosidesGoalsGoldHomologous GeneHumanIn VitroIntegral Membrane ProteinKnowledgeLinkMalignant neoplasm of ovaryMalignant neoplasm of pancreasMapsMembraneMembrane ProteinsMicrosomesModelingModificationMultiprotein ComplexesMutagenesisNegative StainingNormal CellOligosaccharidesPeptidesPlayPolysaccharidesPositioning AttributePreparationProtein BiosynthesisProtein GlycosylationProteinsReactionReceptor Protein-Tyrosine KinasesResearchResolutionRibosomesRoleSamplingSideStructureTransferaseTransmembrane DomainTriplet Multiple BirthTumor MarkersWorkX-Ray CrystallographyYeastsantitumor agentbasecancer cellcancer diagnosiscancer therapydesignflexibilityglycosylationimprovedin vitro activityin vivoinhibitorinsightmimeticsmodel buildingneoplastic cellpolypeptidepreventprogression markerrecruitsecretory proteinsenescencesugartumor diagnosistumor progressiontumorigenesis
项目摘要
Project Summary
Asparagine (N-linked) glycosylation is a ubiquitous modification of eukaryotic secretory and membrane
proteins. N-glycosylation is the most common type of glycosylation, with 90% of glycoproteins being N-
glycosylated. The N-glycans are initially added to a triplet sequence N-X-S/T by a multi-protein transmembrane
complex called oligosaccharyl transferase (OST). Most of the protein N-glycosylation occurs while a protein is
being synthesized by the ribosome and being transported through the translocon. Hence, OST physically
interacts and forms a super-complex with the ribosome and translocon. The mechanisms of protein synthesis
and nascent peptide translocation are better understood thanks to available structures of ribosomes and
translocons. However, our understanding of eukaryotic protein N-glycosylation is very limited due to the lack of
high-resolution OST structures. Our goal is to bridge this major knowledge gap by characterizing the structure
and function of the eight-protein OST complex of yeast. A recent study demonstrated that inhibiting human
OST induces senescence in receptor tyrosine kinase–driven tumor cells, suggesting that OST may be a target
for the development of anti-tumor agents. Furthermore, because transformation of a normal cell to a cancer
cell is usually accompanied by N-glycan branching and extension, several N-glycans have been widely used
as tumor markers: for example, carbohydrate antigen (CA) CA19-9 for detecting pancreatic cancer, and
CA125, which is considered the gold standard marker for diagnosing ovarian cancer. We propose a
comprehensive structure and function study of the yeast OST complex, with a combined approach of cryo-EM,
X-ray crystallography, structure-based mutagenesis and cell biology, and in vitro activity assays. Our work has
important implications in tumorigenesis and cancer diagnosis and treatment.
项目摘要
天冬酰胺(N连接)糖基化是真核秘密和膜的无处不在的修饰
蛋白质。 N-糖基化是最常见的糖基化类型,其中90%的糖蛋白是N-
糖基化。最初通过多蛋白跨膜添加N-聚糖N-X-S/T中
复合物称为寡核酸转移酶(OST)。大多数蛋白质N-糖基化发生在蛋白质是
由核糖体合成并通过易位运输。因此,身体上
与核糖体和易位的相互作用并形成超复合物。蛋白质合成的机制
和新生的意大利辣香肠易位可以更好地理解,感谢您对核糖体的可用结构和
易位。但是,由于缺乏缺乏
高分辨率OST结构。我们的目标是通过表征结构来弥合这一主要知识差距
八蛋白OST酵母菌络合物的功能。最近的一项研究表明,抑制人类
OST在受体酪氨酸激酶驱动的肿瘤细胞中诱导感受,这表明OST可能是一个靶标
为了开发抗肿瘤剂。此外,因为将正常细胞转化为癌症
细胞通常伴随着N-聚糖分支和延伸,几个N-聚糖已被广泛使用
作为肿瘤标记:例如,用于检测胰腺癌的碳水化合物抗原(CA)CA19-9,和
CA125,被认为是诊断卵巢癌的黄金标准标记。我们提出了一个
酵母OST复合物的综合结构和功能研究,具有冷冻EM的综合方法
X射线晶体学,基于结构的诱变和细胞生物学以及体外活性评估。我们的工作有
肿瘤发生,癌症诊断和治疗的重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Huilin Li其他文献
Huilin Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Huilin Li', 18)}}的其他基金
Novel Computational Methods for Microbiome Data Analysis in Longitudinal Study
纵向研究中微生物组数据分析的新计算方法
- 批准号:
10660234 - 财政年份:2023
- 资助金额:
$ 42.59万 - 项目类别:
Molecular mechanisms for sorting lysosomal proteins
溶酶体蛋白分选的分子机制
- 批准号:
10521596 - 财政年份:2022
- 资助金额:
$ 42.59万 - 项目类别:
Molecular mechanisms for sorting lysosomal proteins
溶酶体蛋白分选的分子机制
- 批准号:
10662534 - 财政年份:2022
- 资助金额:
$ 42.59万 - 项目类别:
Molecular mechanisms of protein glycosylation and trafficking
蛋白质糖基化和运输的分子机制
- 批准号:
10655796 - 财政年份:2018
- 资助金额:
$ 42.59万 - 项目类别:
相似国自然基金
非洲猪瘟病毒B475L蛋白靶向LMP2抑制抗原递呈的分子机制
- 批准号:32302894
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于HBV和肝癌相关抗原免疫优势T细胞表位的双靶人工抗原提呈细胞治疗HBV相关肝癌的研究
- 批准号:82303729
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
KIF17介导肿瘤细胞MHC-II胞膜定位促进乳腺癌抗原提呈及免疫应答的机制研究
- 批准号:82372781
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
微量肝癌组织肿瘤新抗原高效稳定深度覆盖鉴定技术研究
- 批准号:32371503
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
钩吻素子对胃癌MHC-I类抗原呈递激活免疫应答的调控及其机制研究
- 批准号:82373138
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Chromatin and immune regulation of tumor growth and progression
肿瘤生长和进展的染色质和免疫调节
- 批准号:
10744436 - 财政年份:2023
- 资助金额:
$ 42.59万 - 项目类别:
Patient-Derived Kidney Organoids For Modeling Kidney Injury
用于肾损伤建模的患者肾脏类器官
- 批准号:
10663719 - 财政年份:2023
- 资助金额:
$ 42.59万 - 项目类别:
Design of the Glomerulus and bOwman cApsuLe on a chip (GOAL)
芯片上肾小球和鲍曼胶囊的设计(目标)
- 批准号:
10810038 - 财政年份:2023
- 资助金额:
$ 42.59万 - 项目类别:
Biomaterial Scaffolds for In Vivo CAR T Cell Manufacture
用于体内 CAR T 细胞制造的生物材料支架
- 批准号:
10739094 - 财政年份:2023
- 资助金额:
$ 42.59万 - 项目类别: